// App-Quantinova.ai

: NEURO-COVID: DOES SEVERE COVID-19 INFECTION INCREASE THE RISK FOR COGNITIVE IMPAIRMENT?

Researchers

Presenter

  • Göran Hagman

Principal Investigators

  • Charlotta Thunborg

  • Pia Andersen

  • Nicholas Levak

  • Malin Aspö

  • Håkan Walles

  • Elias Jokhader

  • Jessica Kåhlin

  • David Nelson

  • Fredrik Piehl

  • Antonios Tzortzakakis

  • Henrik Zetterberg

  • Tobias Granberg

  • Lars I Eriksson

  • Miia Kivipelto

Medical Centers

  • Karolinska Institutet,

  • Karolinksa University Hospital,

  • Medical Unit Aging, Karolinska University Hospital

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • UK Dementia Research Institute

  • Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet

  • Mälardalen University

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

  • Depression

  • Coronavirus disease

  • Dementia

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved